Navigation Links
Microchip Biotechnologies, Inc. Collaborating With Stanford University on Developing a Front End Microfluidic-Based Sample Preparation System for Pyrosequencing Platforms
Date:2/28/2008

DUBLIN, Calif., Feb. 28 /PRNewswire/ -- Microchip Biotechnologies, Inc. (MBI) is collaborating with Stanford University to develop a front-end microfluidic based sample preparation system to generate template libraries for next generation Pyrosequencing. The goal of the project is to automate the complex, multi-step upstream template production using MBI's Microscale-On-chip-Valves (MOV(TM)) for Superscalar Pyrosequencing. "Using MBI's MOV technology to develop and integrate a fully automated sample preparation system will greatly reduce upfront sample preparation time (a key bottle neck in next generation sequencing systems), labor, and reagent costs for customers," indicated Dr. Stevan Jovanovich, President and CEO of MBI. MBI's microfluidic technology has been demonstrated in a number of life science, forensic, and biodefense sample preparation applications.

"By integrating and automating the upstream sample processing, it is envisioned that a mammalian genome can be sequenced in a day," said Mostafa Ronaghi, PhD, senior research scientist and the Principal Investigator of the project at Stanford University.

Pyrosequencing was first introduced by Ronaghi and co-workers in 1996 and commercialized by Pyrosequencing AB in Sweden. Pyrosequencing relies on the bioluminometric real-time detection of inorganic pyrophosphate (PPi) that is released on successful incorporation of nucleotides during DNA synthesis.

About Microchip Biotechnologies

Microchip Biotechnologies Inc. is an early-stage privately-held company located in Dublin, California that is developing advanced programmable fluidic sample preparation and analytical instrumentation for Life Sciences, Applied Sciences, and Diagnostics markets. These solution are based on MBI's proprietary "NanoBioProcessorTM platform and associated "Microscale-on-Chip-Valves" (MOVTM). More details can be found on the Company's website: http://www.microchipbiotech.com.


'/>"/>
SOURCE Microchip Biotechnologies, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Team develops energy-efficient microchip
2. Quick microchip test for dangerous antibiotic resistant bacteria
3. Microchip Biotechnologies, Inc. Secures Exclusive License to Use New University of Alberta Technology for Developing Microfluidic Devices
4. Raven biotechnologies, inc. and Wyeth Pharmaceuticals Extend Evaluation Period of Selected Raven Antibodies
5. Millennium Biotechnologies, Inc. Launches SURGEX(TM) the First Scientifically Validated Sports Nutritional Product Created from the Medical Markets
6. Maven Biotechnologies, LLC to Present at BIOCOM Investor Conference
7. Stanford researchers hear the sound of quantum drums
8. Maxygen to Present at the Stanford Group Company 13th Annual Healthcare Conference
9. Northeastern University and Mass General Hospital Increase the Accuracy, While Reducing the Diagnosis Time, for Breast Cancer Detection
10. Families of Spinal Muscular Atrophy; University of California, Irvine Stem Cell Scientist; and California Stem Cell Announce Collaboration for Safety Studies for Stem Cell Therapy in Spinal Muscular Atrophy
11. Kiwa Bio-Tech Products Group Discusses Cooperative Research With the University of Waterloo, Canada
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/22/2017)... Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN), today announced a ... Biobank and GSK to generate genetic sequence data from the ... will enable researchers to gain valuable insights to support advances ... of serious and life threatening diseases. ... Genetic evidence has revolutionized ...
(Date:3/22/2017)... MONICA, Calif. , March 22, 2017 /PRNewswire/ ... are proud to announce their extended partnership and ... will be headlined by the 21 st ... BIOMEDevice Boston, taking place May 3-4, 2017. ... Advanced Medical Technology Association (ADVAMED) President and CEO, ...
(Date:3/22/2017)... LEXINGTON, Mass. , March 22, 2017   ... collections, today announced that Doctors Pathology Service ... mid-Atlantic region of the United States ... the Delaware Health Information Network (DHIN) to ... researchers. The novel program, announced in ...
(Date:3/22/2017)... /PRNewswire/ - FACIT announced a seed stage investment ... start-up created by FACIT focused on developing a ... with non-dilutive capital, achieves a targeted $3.0M financing ... Propellon to accelerate the nomination of a candidate ... entering a strategic partnership for clinical trials in ...
Breaking Biology Technology:
(Date:3/20/2017)... At this year,s CeBIT Chancellor Dr. Angela Merkel visited the ... the DERMALOG stand together with the Japanese Prime Minster Shinzo Abe. ... largest German biometrics company the two government leaders could see the three ... as DERMALOGĀ“s multi-biometrics system.   Continue Reading ... ...
(Date:3/16/2017)... CeBIT 2017 - Against identity fraud with DERMALOG solutions "Made in Germany ... ... one project, multi-biometric solutions provide a crucial contribution against identity fraud. (PRNewsFoto/Dermalog Identification Systems) ... Used combined in one project, multi-biometric solutions provide a crucial contribution ... ...
(Date:3/9/2017)... , Australia , March 9, ... study data at the prestigious World Lung Imaging Workshop ... Andreas Fouras , was invited to deliver the ... pulmonary medicine. This globally recognised event brings together leaders ... share the latest developments in lung imaging. ...
Breaking Biology News(10 mins):